Syllable
Esther Dyson is the Executive Founder of Wellville, a ten-year, five-community project dedicated to showing the value of investing in health as opposed to spending on care. She is also an angel investor in a variety of sectors, including healthcare. In addition to her investment in Syllable, where she is an advisor, her portfolio includes 23andMe (former director), 4D Healthware, Abridge.ai, BAMF Health (board), Big Health, Bioz, Boundless.ai (sold to Thrive Global), Care.Coach, CareMESH, Cecelia, Clover Health, Devoted Health, Element3 Health (board), Eligible, Empathic Technologies, Enso Relief, Epistemic.ai, Ezra.com, Hawthorne Effect, HealthCelerate, HealthTap, Humanity, Hurdle, i2Dx, Lipidio, LuminDx, MealShare, Medesk, MedicaSafe, meQuilibrium, Mindright.io, Nanowear, NeuroGeneCES, Nuna, Omada Health, PatientsKnowBest, Pocket Naloxone, Prognos.ai, Proofpilot, Resilient, Solera, Startup Health, Supportiv, Tega, Tocagen, Virgo SVS, and X-Vax. Follow Esther on Twitter: @edyson.
This person is not in the org chart
This person is not in any offices
Syllable
1 followers
Syllable brings empathy, transparency, and intelligence to every patient touchpoint outside the hospital. In 2020, Syllable communicated with 45 million Americans through text and chat about access to care related to appointments, primary care, specialty care, and COVID-19.